Scale, scope, and spillovers: the determinants of research productivity in drug discovery.
Rand J Econ
; 27(1): 32-59, 1996.
Article
em En
| MEDLINE
| ID: mdl-10160535
ABSTRACT
We examine the relationship between firm size and research productivity in the pharmaceutical industry. Using detailed internal firm data, we find that larger research efforts are more productive, not only because they enjoy economies of scale, but also because they realize economies of scope by sustaining diverse portfolios of research projects that capture internal and external knowledge spillovers. In pharmaceuticals, economies of scope in research are important in shaping the boundaries of the firm, and it may be worth tolerating the static efficiency loss attributable to the market power of large firms in exchange for their superior innovative performance.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Pesquisa
/
Indústria Farmacêutica
/
Eficiência
Limite:
Humans
Idioma:
En
Revista:
Rand J Econ
Assunto da revista:
SERVICOS DE SAUDE
Ano de publicação:
1996
Tipo de documento:
Article
País de afiliação:
Estados Unidos